Adaptive Biotechnologies (ADPT) Short-term Investments (2018 - 2026)

Adaptive Biotechnologies (ADPT) has 9 years of Short-term Investments data on file, last reported at $140.8 million in Q1 2026.

• Quarterly Short-term Investments fell 1.42% year-over-year to $140.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $140.8 million (down 1.42% YoY) and the FY2025 annual result came in at $156.5 million, down 10.26% from the prior year.
• Short-term Investments eased to $140.8 million in Q1 2026 per ADPT's latest filing, from $156.5 million in the prior quarter.
• The five-year high for Short-term Investments was $408.2 million in Q4 2022, with the low at $140.8 million in Q1 2026.
• Average Short-term Investments over 5 years is $239.7 million, with a median of $237.6 million recorded in 2024.
• The widest YoY moves for Short-term Investments: up 90.74% in 2022, down 53.99% in 2022.
• Adaptive Biotechnologies' Short-term Investments stood at $408.2 million in 2022, then plunged by 31.07% to $281.3 million in 2023, then slumped by 38.02% to $174.4 million in 2024, then fell by 10.26% to $156.5 million in 2025, then fell by 10.05% to $140.8 million in 2026.
• Business Quant data shows ADPT's Short-term Investments at $140.8 million in Q1 2026, $156.5 million in Q4 2025, and $157.7 million in Q3 2025.